Skip to main content
. 2013 May 31;15(2):90–98. doi: 10.5853/jos.2013.15.2.90

Table 1.

A comparison of the current thrombolytic drugs that are available in term of plasma half life, fibrin specificity and susceptibility to inhibition57

graphic file with name jos-15-90-i001.jpg